Arecor Achieves Second License Milestone Payment from Global Pharmaceutical Partner
Arecor formulated biosimilar product progressing through clinical studies
Cambridge, UK., 25 February 2020: Arecor Ltd (“Arecor” or “the Company”), the biopharmaceutical company advancing today’s therapies to enable healthier lives, today announces that it has achieved an important second, contractual milestone with one of its pharmaceutical partners. The first milestone was triggered in October 2017 following the signature of a license agreement between the parties.
In accordance with the license agreement…
Colleagues from TTP will be supporting and attending this one-day matchmaking event - do not miss it.
Information from the organisers: Imperial College London, NIHR and the NHS
PROBLEM
Less than 1% of proposed Biomarkers achieve clinical adoption and there is a wide gulf between those published in academic journals and those being translated onto scalable platforms that can be integrated into healthcare systems.
Earlier consideration of Biomarker platform should improve the efficiency and robustness of the research and enhance the likelihood
of the end product being clinically useful. This…
Air Liquide are pleased to announce the introduction of their new e-Mixture guide. It’s a familiar problem for laboratory technicians: you need a particular gas mixture – perhaps for calibration - but you don’t know exactly what data you need to provide to be sure that the mixture complies with the correct specifications. Not only that, the cost or delivery deadline might not be immediately clear. Air Liquide’s new e-Mixture Guide offers a ready-made answer to all these questions.The e-Mixture guide is a smart, powerful and user-friendly online tool, which guides customers…
Following a year of strong growth and successful acquisitions, Entrust People and SCI Search & Selection are merging to become Entrust Resource Solutions.
This new brand better represents the future of our group of recruitment consultancies and is a massive step towards us realising our vision of providing the very best, fully accountable, bench to board talent solution.
Our merger will enable us to better serve our clients and candidates as one larger, consolidated team strategically positioned in thriving life science hubs across the UK: Dundee, Northwich and our executive search brand…
The next SysMIC Module 1 course will start on Monday 27th April 2020
SysMIC was developed with BBSRC funding and provides introductory and advanced training in mathematics, statistics and computing for bioscientists. SysMIC is a comprehensive online course in interdisciplinary skills in the life sciences with over 2,000 participants enrolling since its beginning in 2013.
Key topics are:
• Network biology
• Mechanistic modeling, and
• Data analysis
Participants will gain an understanding of:
• Programming in Python, MATLAB and R
• Analysing, modelling and simulating biological systems
•…
Cambridge, UK, 13th February 2020 / Sciad Newswire / Domainex Ltd is pleased to announce the appointment of Dr Tom Mander as Chief Executive Officer. Dr Mander will take over when Dr Trevor Perrior retires from the role in April 2020. Tom has nearly 30 years of experience in small-molecule drug discovery, and joined Domainex as Chief Operating Officer in March 2015 with a mandate to achieve organic expansion of the drug discovery service business of the company.
Trevor Perrior, CEO of Domainex, said, “I am very pleased that Tom has agreed to take over as Chief Executive. Tom joined the…
Cambridge, UK, 13 February 2020: Sphere Fluidics, a company commercializing single cell analysis systems underpinned by its patented picodroplet technology, today announced investment in the production and supply of its proprietary biocompatible surfactant, Pico-Surf™, for reliable and highly stable droplet generation and processing. Sphere Fluidics will expand operations to meet demand for large-scale commercial supply of its high-performing surfactant for use in a wide range of microfluidic application workflows.
Pico-Surf is a high-quality and animal-origin-free…
CAMBRIDGE, UK and NEW YORK, USA, 10 February 2020 Artios Pharma Limited (Artios), a leading DNA Damage Response (DDR) company developing a broad pipeline of innovative treatments for cancer, today announces the appointment of Bryony Harrop as Vice President (VP) of Clinical Development, Bryony will be working alongside Dr Gillian Langford, also VP of Clinical Development, who joined Artios in January 2019.
Bryony will report directly to Chief Medical Officer, Dr Ian Smith, and in collaboration with Gillian will be responsible for the clinical development strategy, regulatory, and…
LOUGHBOROUGH, England (February 3, 2020) – Thermo Fisher Scientific, the world leader in serving science, recently announced the winners of the Fisher Scientific Channel Supplier Awards during its annual Fisher Scientific European Sales Conference held in Madrid.
From January 27-30, 2020, a total of 817 delegates attended the Fisher Scientific European Sales Conference at the Melia Castilla hotel in Madrid. This was the ninth event of its kind, bringing together delegates from 23 different countries.
The event, themed Lead with Purpose, included an exhibition showcase with 65 booths featuring…
With the transition period for the new European Medical Device Regulation (EU) 2017/745 (MDR) coming to an end in May 2020, it is imperative that manufacturers take action to update their technical documentation and processes to meet the new requirements.
The MDR, which replaces the Medical Devices Directive (93/42/EEC), brings with it more scrutiny of technical documentation, addressing concerns over the assessment of product safety and performance by placing stricter requirements on clinical evaluation and post-market clinical follow-up and requiring better traceability of devices through…